CN8 A/S: Financial statements 2024
CVR: 42822604
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
CN8 A/S (CVR 42822604) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -55,000 and a net result of DKK 20,527,000 compared with DKK -28,046 the year before. Equity in the 2024 report amounted to DKK 6,897,978,000. The solvency ratio was 99.9%.
- Gross Profit
- DKK -55,000
- Profit/Loss
- DKK 20,527,000
- Equity
- DKK 6,897,978,000
- Total Assets
- DKK 6,903,810,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -55 t. | 20.5 mio. | 6.9 mia. | - |
| 2023 | - | -36 t. | -28 t. | 2 t. | - |
| 2022 | - | -13 t. | -10 t. | 30 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of September 3, 2024, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of CN8 A/S.
As of September 3, 2024, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of CN8 A/S.
As of April 23, 2024, Arne Due-Hansen has joined the board of directors of CN8 A/S.
As of April 23, 2024, Peter Rothaus Rothausen has joined the board of directors of CN8 A/S.
On April 23, 2024, the company changed its name from TWH VII A/S to CN8 A/S.
As of April 23, 2024, LUNDBECKFOND INVEST A/S is registered as an owner of CN8 A/S with an ownership share of 15%.
As of April 23, 2024, T&W Medical A/S is registered as an owner of CN8 A/S with an ownership share of 66%.
As of April 17, 2024, Jan Tøpholm has joined the board of directors of CN8 A/S.
As of April 17, 2024, Adam Westermann has joined the board of directors of CN8 A/S.
As of April 17, 2024, Julian Tøpholm has joined the board of directors of CN8 A/S.
About CN8 A/S
CN8 A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2021. The company is registered under the industry Investering for egen regning. The company was previously named TWH VII A/S and TWH VII ApS. The management consists of Lars Nørgaard. The board consists of Julian Tøpholm (chair), Arne Due-Hansen, Adam Westermann and Jan Tøpholm. The company is owned by LUNDBECKFOND INVEST A/S and T&W Medical A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -1,595,000 and a net result of DKK 21,695,000 compared with DKK 20,527,000 the year before. Equity in the 2025 report amounted to DKK 7,566,544,000.